300
Views
84
CrossRef citations to date
0
Altmetric
Research Article

Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro

&
Pages 307-315 | Published online: 09 Jul 2009

  • Hahn, GM. Interactions of drugs and hyperthermia in vitro and in vivo. In: Streifer C, von Beuringen D, Dietzel F, Rottinger E, Robinson JE, Scherer E, Saber S, Trott KR, eds. Cancer Therapy by Hyperthermia and Radiation. Baltimore and Munich: Urban & Schwarzenberg. 1978; 72-9.
  • Johnson HA, Pavelec, M. Thermal enhancement of thio-TEPA cytotoxicity. J Nail Cancer Inst 1973; 50: 903-8.
  • Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures a review. Int J Hyperthermia 1999; 15: 79-107.
  • Uenard D, Eggermont AMM, Koops HS, Kroon BBR, Rosenkaimer F, Autier P, Lejeune FJ. Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-a), interferon-gamma (INF-7) and melphalan for melanoma stage III. Results of a multi-centre pilot study. Melanoma Res 1994; 4: 21-6.
  • Olieman AFT, Pra E, van Ginkel RJ, Molenaar WM, Koops HS, Hoekstra HJ. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-a and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 1998; 40: 807-14.
  • Lehti PM, Moseley HS, Janoff K, Steven K, Fletcher WS. Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy. Surg Gynecol Obstet 1986; 162: 149-52.
  • Kuroda M, Urano M, Nishimura Y, Reynolds R. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma. Int J Radiat Oncol Biol Phys 1997; 38: 411-7.
  • Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritond syndrome. Eur J Surg Oncol 2001; 27: 239-43.
  • Takemoto M, Kuroda M, Urano M, Nishimura Y, Kawasaki S, Kato H, Okumura Y, Akaki S, Kanazawa S, Hiraki Y. The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumors. Int J Hyperthermia, submitted.
  • Mathe G, Kidani Y, Segiguchi M, Eriguchi M, Fredj G, Peytavin G, Misset JL, Brienza S, de Vassals F, Chenu E, Bourut C. Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum. Blamed Pharmacother 1989; 43: 237-50.
  • Saris CP, van de Vaart PJM, Rietbroek RC, Bloommaert FA. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells. Carcinogenesis 1996; 17: 2763-9.
  • Urano M, Kahn J, Kenton LA. The effect of tis-diamminedichloroplatinun(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. Int J Hyperthermia 1990; 6: 563-70.
  • Urano M., Kahn J., Majima H., Gerweck LW. The cytotoxic effect of cis-diamminedichloroplatinum (II) on cultured Chinese hamster cells at elevated temperatures. Int J Hyperthermia 1990; 6: 581-90.
  • Majima H, Kashiwado K, Egawa S, Suzuki N, Urano M. Interaction between the kinetics of thermotolerance and the effect of cis-diamminedichloroplatinum(II) or bleomycin given at 37 or 430C. Int J Hyperthermia 1992; 8: 431-42.
  • Rietbroek RC, van de Vaart PJM, Haveman J, Blommaert FA, Geerdink A, Bakker PJM, Veenhof CHN. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells. J Cancer Res Clin Oncol 1997; 123: 6-12.
  • Majima H, Urano M, Sougawa M, Kahn J. Thermal and radiation sensitivity of mouse fibrosarcoma cells recurrent after large single radiation dose. Int J Radiat Oncol Biol Phys 1992; 22: 1019-28.
  • Westra A, Dewey WC. Variation in sensitivity to heat shock during the cell-cycle of Chinese hamster cells in vitro. Int J Radiat Biol 1997; 19: 467-77.
  • Dahl D. Mechanisms of thermal enhancement of chemotherapeutic cytotoxicity. In: Urano M, Douple E, eds. Hyperthermia and Oncology, vol 4, Utrecht, The Netherlands VSP, 1996; 9-28.
  • Song CW, Shakil A, Osborn JL, Iwata K.. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 1996; 12: 367-73.
  • Bronk BV, Wilkins RJ, Regan JD. Thermal enhancement of DNA damage by an alkylating agent in human cells. Biochem Biophys Res Commun 1973; 52: 1064-70.
  • Murray D, Milas L, Meyn RE. DNA damage produced by combined hyperglycemia and hyperthermia in two mouse fibrosarcoma tumors in vivo. Int J Radiat Oncol Biol Phys 1980; 10: 1679-82.
  • Pinto AL Lippard SJ. Binding of the antitumor drug cis-diamminedichloroplatinurr(II) (Cisplatin) to DNA. Biochem Biophys Acta 1985; 780: 167-80.
  • Reed E, Ozols RF, Tarone R, Yuspa SH, Poirier MC. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinumbased chemotherapy. Proceed. Natl Acad Sci 1987; 84: 5024-8.
  • Meyn RE, Corry PM, Fletcher SE, Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(I). Cancer Res 1980; 40: 1136-9.
  • Urano M, Kim MS, Kahn J, Kenton LA, Li ML. Effect of thermochemotherapy (combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma. Cancer Res 1985; 45: 4162-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.